| Literature DB >> 23971674 |
Jeffrey M Muir1, Chenglin Ye, Mohit Bhandari, Jonathan D Adachi, Lehana Thabane.
Abstract
BACKGROUND: Physical activity is known to benefit many physiological processes, including bone turnover. There are; however, currently no clinical guidelines regarding the most appropriate type, intensity and duration of activity to prevent bone loss.Entities:
Mesh:
Year: 2013 PMID: 23971674 PMCID: PMC3765292 DOI: 10.1186/1471-2474-14-253
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1CONSORT flow chart summarizing participant eligibility criteria and resulting number of participants.
Summary of selected demographic and anthropometric characteristics of the study participants
| Age | 79.84 ± 4.43 |
| | |
| 75-79 | 646 (55.3%) |
| 80-84 | 337 (28.8%) |
| 85-89 | 143 (12.2%) |
| 90-94 | 39 (3.3%) |
| 95+ | 4 (0.3%) |
| Height in cm | 156.6 ± 6.5 |
| Weight in kg | 64.2 ± 12.1 |
| Body Mass Index (BMI) | 26.2 ± 6.5 |
| Osteoporosis diagnosis? | |
| Yes | 506 |
| No | 597 |
| Osteoporosis treatment? | |
| Yes | 388 |
| No | 177 |
| Race | |
| White | 11441 |
| Chinese | 14 |
| South Asian | 1 |
| Black | 4 |
| Native/Aboriginal | 21 |
| Arab/West Asian | 0 |
| Filipino | 1 |
| South East Asian | 1 |
| | 1 |
| Latin American | 2 |
| Japanese | 0 |
| Korean | 0 |
| Medication | |
| Currently taking antiresorptive medication | 85 (15%) |
SD standard deviation.
BMI body mass index.
1 one respondent identified herself as both “white” and “native/aboriginal”.
Summary of level of participation in each category of activity for female participants aged 75 years and older over the 12 months prior to study enrollment, in hours/week
| | ||||||||
| Moderate | 76 (6.5) | 94 (8.0) | 163 (13.9) | 189 (16.2) | 222 (19.0) | 219 (18.7) | 130 (11.1) | 76 (6.5) |
| Strenuous | 1133 (96.9) | 15 (1.3) | 17 (1.5) | 2 (0.2) | 1 (0.1) | 1 (0.1) | n/r2 | n/r |
| Vigorous | 1128 (96.4) | 31 (2.7) | 8 (0.7) | 2 (0.2) | n/r | n/r | n/r | n/r |
1 participants indicated their level of participation for each of moderate, strenuous and vigorous levels.
2 no respondents for this category.
Distribution of selected pharmacological interventions used by study participants
| Hormone replacement therapy | 102 | 8.7 | 1067 | 91.3 |
| Bisphosphonates | 50 | 4.3 | 1119 | 95.7 |
| Selective Estrogen Receptor modulators | 5 | 0.4 | 1164 | 99.6 |
| Corticosteroids | 38 | 3.3 | 1131 | 96.7 |
Effect of increasing amounts of daily moderate physical activity on bone density at various body sites in study participants
| Lumbar spine | -0.006 | [-0.013, 0.00] | 0.066 |
| Femoral neck | 0.006 | [0.002, 0.010] | 0.006* |
| Total hip | 0.008 | [0.002, 0.013] | 0.004* |
| Trochanter | 0.006 | [0.002, 0.011] | 0.004* |
* statistically significant.
Results from multiple regression analysis of the relative effects of moderate activity and secondary factors on bone mineral density at various body sites
| Moderate activity | Lumbar spine (L1-4) | -0.006 [-0.013, 0.000] | 0.067 |
| Femoral neck | 0.004 [0.000, 0.008] | 0.042* | |
| Total hip | 0.006 [0.001, 0.011] | 0.019* | |
| Ward’s triangle | 0.004 [-0.001, 0.009] | 0.132 | |
| Trochanter | 0.005 [0.001, 0.009] | 0.018* | |
| Anti-resorptive therapy | Lumbar spine (L1-4) | 0.040 [0.006, 0.074] | 0.021* |
| Femoral neck | 0.022 [0.001, 0.043] | 0.038* | |
| Total hip | 0.017 [-0.008, 0.042] | 0.175 | |
| Ward’s triangle | 0.016 [-0.009, 0.041] | 0.213 | |
| Trochanter | 0.004 [-0.017, 0.025] | 0.731 | |
| Body mass index | Lumbar spine (L1-4) | 0.011 [0.008, 0.014] | 0.001* |
| Femoral neck | 0.008 [0.006, 0.010] | 0.001* | |
| Total hip | 0.011 [0.009, 0.013] | 0.001* | |
| Ward’s triangle | 0.007 [0.006, 0.009] | 0.001* | |
| Trochanter | 0.008 [0.007, 0.010] | 0.001* | |
| Age (years) | Lumbar spine (L1-4) | -0.002 [-0.005, 0.002] | 0.293 |
| Femoral neck | -0.005 [-0.007, -0.003] | 0.001* | |
| | Total hip | -0.006 [-0.009, -0.004] | 0.001* |
| Ward’s triangle | -0.005 [-0.008, -0.003] | 0.001* | |
| Trochanter | -0.004 [-0.006, -0.002] | 0.001* |
* statistically significant.